Market Research Blog – Page 1848 – New Product Development

Neurovascular Guidewires Market is expected to grow at a 4.0% annual rate between 2022 and 2028 | FMI

The Neurovascular Guidewires Market, a crucial tool in minimally invasive spine and cervical surgeries, is experiencing steady growth. According to a recent analysis, the global Neurovascular Guidewires Market is expected to reach USD 399.1 million by 2028. This translates to a projected CAGR (Compound Annual Growth Rate) of 4.0% from 2022 to 2028.

According to a new research study by Future Market Insights, Straight tip guidewires, with a current share of more than a third of the total market value, will retain the dominant position in the neurovascular guidewires market through 2028.

Aneurysms and intra-and extra-cranial angioplasty reflect the highest applicability of neurovascular guidewires.
Hospitals, though anticipated to reflect limited investment opportunities in the neurovascular guidewire market, will remain the leading end-use segment with the maximum share in terms of revenue generation.

Get Sample Report + Related Graphs & Charts
https://www.futuremarketinsights.com/reports/sample/rep-gb-3121

The Increasing Number of Neurovascular Disease Treatment Alternatives

Neurovascular guidewires, among the latest innovations in the neurovascular disease treatment landscape, has been pushing the number of neurovascular surgeries since their introduction. This according to the report will remain a key factor sustaining demand for neurovascular guidewires in the global market over the coming years.

As the advent of technology used in neurovascular surgeries has significantly increased the number of treatment options for neurovascular diseases, the treatment by using neurovascular guidewires is gaining ground rapidly owing to the relatively lower risk associated with surgical treatment, over conventional surgeries. The usage of guidewires is the mainstay for neurovascular therapy, along with new technologies such as coating-based guidewires, which has contributed substantially to the treatment options for complex lesions that are treated surgically.

The increasing number of neurovascular neuroradiology procedures is also boosting the demand for access products, which is another factor driving the neurovascular guidewires market. The number of neurovascular interventions is increasing with growing awareness among surgeons about the cost benefit associated with the neurovascular guidewires. Besides, reimbursement policies for outpatient surgeries are also expected to propel the neurovascular guidewires market revenue. Furthermore, an increase in the number of end users such as ambulatory surgical centers in underdeveloped and developing countries is boosting the number of outpatients cases, which is also expected to drive the overall market for neurovascular guidewires.

Favorable Reimbursement Scenario & Government Support

The growing prevalence and incidence of cerebral infarction, aneurysm, and stroke is projected to fuel the demand for neurovascular guidewires. Growth in the number of patients suffering from ischemic stroke across the world is also estimated to boost the adoption of neurovascular guidewire and contribute to the growth of the global neurovascular guidewire market during the forecast period.

Similarly, increasing incidence of arteriovenous malformations is also contributing to growth in the demand for neurovascular guidewires. The increasing prevalence of intracranial and extracranial angioplasty is another factor that is expected to drive the neurovascular guidewires market.

Neurovascular guidewires are effective and safe devices in neurovascular intervention procedures for patients suffering from neurovascular diseases. Modifications in reimbursement policies are encouraging the number of outpatients in developed countries. Government initiatives and local reimbursement policies about the usage of neurovascular guidewires are also expected to boost the neurovascular guidewire market over the forecast period.

Rising awareness about cerebral infarction is also estimated to contribute to the growth of the market. The reimbursement policies for the treatment of brain aneurysm are also contributing to the growth of the neurovascular guidewires market as the patients are not required to pay from their own pocket.

FMI’s report tracks some of the key companies operating in the neurovascular guidewire market, which include Boston Scientific Corporation, Medtronic, Penumbra Inc., Stryker, Asahi Intecc Co. Ltd, Integer Holding Corporation, Cordis Corporation, CONMED Corporation, phenox GmbH, and Integer Holding Corporation, among others.

Request Discount
https://www.futuremarketinsights.com/request-discount/rep-gb-3121

Neurovascular Guidewires Market by CategoryProduct:

Shapeable Tip Guidewires
Straight Tip Guidewires
Angled Tip Guidewires
Round curve Tip Guidewires

Application:

Arteriovenous Malformations
Intracranial and Extra-Cranial Angioplasty
Aneurysms
Minimally Invasive Spine surgery
Cerebral Angiography

Coating Type:

Hydrophilic Guidewires
Hydrophobic Guidewires

End User:

Hospitals
Laboratories
Research Institutes
Biopharmaceutical Companies
Others

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Non-UV Dicing Tapes Market to Witness Strong Growth USD 2.8 Billion by 2033 at a 6.0% of CAGR

The global market for non-UV dicing tapes market is poised for significant expansion in the coming decade, driven by the increasing demand for miniaturization in electronic devices and the rapid growth of the Internet of Things (IoT). According to a recent market analysis, the market size is expected to reach USD 1.59 billion in 2023 and is projected to grow at a robust compound annual growth rate (CAGR) of 6.0%, reaching approximately USD 2.8 billion by 2033.

Non-UV dicing tapes play a crucial role in semiconductor manufacturing processes, facilitating the dicing and separation of semiconductor wafers into individual semiconductor chips. With the proliferation of IoT devices and advancements in miniaturization technologies, the demand for non-UV dicing tapes is expected to surge across various industries including electronics, telecommunications, and automotive.

The trend toward downsizing and the proliferation of Internet of Things (IoT) devices raise the need for non-UV dicing tapes as manufacturers search for dependable solutions to meet the stringent requirements of modern semiconductor fabrication. The convergence of IoT, 5G, and downsizing underscores the pivotal function of non-UV dicing tapes in enabling the seamless operation of next-generation electronic devices, hence driving the market’s rapid expansion.

Get a Sample of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-10866

Key points:

Enhanced Yield and Quality: Non-UV dicing tapes offer superior adhesion and stability, minimizing wafer breakage and improving yield rates during the dicing process, ultimately leading to higher-quality chips.
High-Temperature Resistance: These tapes are designed to withstand the high temperatures generated during dicing, ensuring reliable performance and avoiding tape residue or damage to the wafer surface.
Minimal Residue and Clean Removal: Non-UV dicing tapes leave minimal residue on the wafer after removal, reducing the need for additional cleaning processes and enhancing overall production efficiency.
Compatibility with Advanced Materials: The market provides non-UV dicing tapes that are compatible with various advanced semiconductor materials, such as silicon carbide (SiC) and gallium nitride (GaN), meeting the evolving needs of the industry.
Customization Options: Non-UV dicing tapes can be customized to different wafer sizes and thicknesses, ensuring precise and secure bonding during the dicing process.
Environmental Considerations: Many non-UV dicing tapes are designed with eco-friendly materials and processes, aligning with the industry’s focus on sustainability and reducing environmental impact.

Growth Opportunities in the Non-UV Dicing Tapes Market:

Increased Semiconductor Demand: With the proliferation of electronics in various industries, the demand for semiconductor chips is on the rise, consequently driving the demand for non-UV dicing tapes used in semiconductor manufacturing.
Technological Advancements: Ongoing advancements in semiconductor manufacturing technologies are creating opportunities for the development of more efficient and precise non-UV dicing tapes, enhancing productivity and yield rates.
Expanding Electronics Industry: The expanding consumer electronics market, coupled with the growing adoption of IoT devices and wearable technology, presents significant growth prospects for the non-UV dicing tapes market as these devices require semiconductor components.
Rising Automotive Sector: The automotive industry’s increasing integration of advanced electronics and semiconductor components in vehicles, including electric vehicles and autonomous driving systems, is driving the demand for non-UV dicing tapes for semiconductor packaging.
Emerging Markets: Emerging economies, particularly in Asia-Pacific, are witnessing rapid industrialization and infrastructural development, creating a conducive environment for the growth of the non-UV dicing tapes market due to increased semiconductor manufacturing activities.

Upcoming Trends in the Non-UV Dicing Tapes Market:

Miniaturization in Electronics: The trend towards miniaturization of electronic devices and components is driving the demand for thinner and more precise non-UV dicing tapes to enable the dicing of smaller semiconductor chips.
Shift Towards Wafer-Level Packaging: The semiconductor industry is increasingly adopting wafer-level packaging techniques for cost reduction and improved performance, which necessitates advanced non-UV dicing tapes to facilitate the process.
Demand for Environmentally Friendly Solutions: Growing environmental concerns are prompting manufacturers to develop eco-friendly non-UV dicing tapes with reduced environmental impact, aligning with sustainability goals and regulations.
Integration of Advanced Materials: The integration of advanced materials such as polymers and nanomaterials in non-UV dicing tapes is poised to enhance their mechanical properties, thermal stability, and overall performance in semiconductor manufacturing processes.
Focus on Process Automation: Automation and robotics are becoming integral in semiconductor manufacturing processes, including dicing operations. Non-UV dicing tapes compatible with automated handling systems are anticipated to gain traction as manufacturers strive for greater efficiency and accuracy.

Leading Key Companies:

Pantech Tape Co. Ltd.; Furukawa Electric Co. Ltd.; Mitsui Chemicals Inc.; AI Technology, Inc.; LINTEC Corporation; QES GROUP BERHAD; MTI Co. Ltd.; Han Kook Tapes Sdn Bhd; NIITO DENKO CORPORATION; Schenzhen Xinst Technology Co. Ltd.

Seize the Opportunity: Get Report Now for a Thorough Report
https://www.futuremarketinsights.com/checkout/10866

Market Segmentation:

By Region:

North America
Latin America
Europe
Middle East and Africa (MEA)
East Asia
South Asia
Oceania

By Material Type:

PVC
PET
PO
Others (EVA, etc.)

By Thickness:

85-125 Micron
126-150 Micron
Below 85 Micron
Above 150 Micron

By Coating Type:

Single Sided
Double Sided

By Application:

Wafer Dicing
Package Dicing
Others (Glass, Ceramics)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer, Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Optical Films Market Anticipates Strong Growth USD 35,455.1 Million by 2032 at a 6.2% of CAGR

The optical films market is poised for substantial growth in the coming decade, bolstered by advancements in semiconductor technology and the increasing adoption of optical components in laser applications. According to the latest forecast from industry analysts, the market, which was valued at USD 19,447.2 million in 2022, is projected to expand at a steady compound annual growth rate (CAGR) of 6.2%, reaching a valuation of USD 35,455.1 million by 2032.

Optical films play a critical role in various applications, serving as antireflection coatings for camera lenses, cold mirrors for lighting, and integral components in semiconductor and laser technologies. As the demand for high-performance optical solutions rises across industries such as electronics, automotive, and telecommunications, the market for optical films continues to grow.

Request for a Sample of this Research Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-6647

With exalted demand for tablets, smartphones, and various other electronic devices all across, the global optical films market is expected to grow on an exuberant note in the forecast period. Also, with smartphones and smart televisions witnessing turbulence on technological grounds, the global optical film market is slated to grow irrevocably in the forecast period.

Characteristics such as exceptional contrast, increased brightness, reduction of glare, uniformity of color, and enhanced readability in televisions, laptops & desktops, automotive displays, tablets, smartphones, and advertising & signage display boards are expected to take the optical films market to a greater ‘high’ in the forecast period.

Future Market Insights has etched these findings with insights in its latest market study entitled ‘Optical Films market’. It has its indigenous team of analysts and consultants to deploy a bottom-up approach across macros and micros.

“With realization of the fact that optical films do cover infrared and ultraviolet wavelengths, the global optical film market is likely to grow well in the forecast period”, says an analyst from Future Market Insights.

Market Drivers:

Consumer Electronics Growth: The increasing demand for consumer electronics, such as smartphones, tablets, laptops, and TVs, often drives the demand for optical films. These films are used in displays to enhance clarity, brightness, and viewing angles.
Advancements in Display Technologies: Innovations in display technologies, such as OLED (Organic Light Emitting Diode) and HDR (High Dynamic Range), may drive the need for specialized optical films to improve performance and visual quality.
Automotive Display Applications: The automotive industry’s integration of advanced display technologies in vehicles, including heads-up displays (HUDs) and in-car entertainment systems, can boost the demand for optical films.
Energy Efficiency: Optical films are used in various applications to enhance energy efficiency by reducing glare and improving light transmission. The growing emphasis on energy-efficient solutions may drive the adoption of optical films in windows, solar panels, and other applications.
Increasing Demand for Thin and Lightweight Devices: As the trend towards thinner and lighter devices continues, optical films that are thin, flexible, and lightweight become more crucial in meeting design and performance requirements.

Market Restraints:

Price Sensitivity: The optical films market can be affected by price sensitivity, particularly in consumer electronics markets. Manufacturers may face challenges in balancing cost considerations with the need for high-performance optical films.
Competitive Market: The optical films industry is competitive, with several players vying for market share. Intense competition can lead to pricing pressures and reduced profit margins.
Global Economic Conditions: Economic downturns or uncertainties can impact consumer spending on electronics and other products, affecting the overall demand for optical films.
Environmental Concerns: Increasing awareness and regulations related to environmental sustainability may impact the choice of materials used in optical films and influence market trends.
Rapid Technological Changes: The fast-paced nature of technological advancements in the display industry can pose challenges for manufacturers, as they need to adapt quickly to new requirements and standards.

Key Takeaways from Optical Film Market

The Asia-Pacific holds the largest market share with Japan and South Korea being home to various key players like Samsung Electronics, Sony Corp., Panasonic Corp, LG Electronics, and likewise.
North America holds the second-largest market share with the US witnessing technological upgradations on continuous basis.
Europe holds more than 20% of the market share and the situation is expected to remain unchanged even going forward. This could be credited consumers’ increasing inclination toward innovations in the device features with globalization to add.

Competitively Optical Films

WeeTect has its anti-glare solutions for solving window and screen glare problems since 2018.
Sumitomo Chemical, in April 2019, entered into collaboration with Zymergen for developing specialty materials inclusive of optical films for flexible electronics circuits, displays, hard coatings devoid of scratch, and likewise.

The Major Key Players Are:

Nitto Optical Co., Ltd.,
Sumitomo Chemical Co. Ltd.,
LG Chemical Ltd.,
Samsung SDI (Formerly Cheil Industries),
BenQ Materials Corp.,
Sanritz Co., Ltd.,
Zeon Corporation,
3M Company,
American Polarizers, Inc.,
Toray Industries, Inc.,
Toyobo Co. Ltd.,
China Lucky Film Group Corporation,
others

Seize the Opportunity: Get Report Now for a Thorough Report
https://www.futuremarketinsights.com/checkout/6647

Key Segmentation:

By Type:

Surface Treatment Film
PVA Film & Protection
PET Protection & Release Film
Reflector Film
Light Guide Plate

By Function:

Display Surface Films
Brightness Enhancement Films
Light Control/Privacy Films

By Application:

Smartphones
TV
Laptops
Tablets
Billboards

By Region:

North America
Latin America
Asia Pacific
MEA
Europe

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer, Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Dialyzer Reprocessing Machines and Concentrates Market is expected to grow steadily at a 5.4% of CAGR and reach USD 2.2 Billion by 2034 | FMI

The Dialyzer Reprocessing Machines and Concentrates Market is experiencing a surge in eco-conscious healthcare. This industry, focused on reusing dialyzers in kidney dialysis treatment, is projected to reach a substantial USD 2,198.2 million by 2034. This significant growth builds on a successful 2023 market value of USD 1,234.1 million. Analysts predict a steady growth trajectory at a Compound Annual Growth Rate (CAGR) of 5.4% over the next decade.

Dialysis continues to be highly preferred for the effective treatment of chronic kidney diseases (CKD) among the geriatric population, thereby generating substantial demand for reusable dialysis equipment.

This, in turn, is foreseen to create revenue-generating opportunities for the companies operating in the Global Dialyzer Reprocessing Machines and Concentrates Industry.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-9272

North America Continues to Mark the Most Significant Position in the Market

According to the report, rising instances of renal disorders, such as end-stage renal disease (ESRD) and chronic kidney disease (CKD), are among the key factors spurring the growth of dialyzer reprocessing machines and concentrates market. Dialysis, being the most accessible treatment for kidney diseases, will thus continue to add to the overall importance of reusable dialysis equipment. This, in turn, will create favourable grounds for the adoption of Global Dialyzer Reprocessing Machines and Concentrates Industry.

In 2015, it was estimated by the National Kidney Foundation in the US that approximately 468,000 ESRD patients were reported to be on dialysis in the US alone. North America will thus continue to be a prominent region in the Global Dialyzer Reprocessing Machines and Concentrates Industry, followed by South Asia. In 2018, North America accounted for a revenue share of around 24% in the Global Dialyzer Reprocessing Machines and Concentrates Industry, backed by a robust healthcare infrastructure.

India, Sri Lanka, and, Thailand on the other side are likely to emerge as potential countries brimming with prime opportunities for the companies operating in the Global Dialyzer Reprocessing Machines and Concentrates Industry.

According to the report, the introduction of technologically advanced medical equipment aligned with the evolving healthcare models is further expected to boost the growth of the Global Dialyzer Reprocessing Machines and Concentrates Industry. dialyzer reprocessing machines and concentrates enable automated cleaning and reprocessing of the dialysis units, unlike the traditional re-usable systems that require manual handling.

As per the research study, dialyzer reprocessing machines provide immense scope for direct handling of dialysis systems using automated digital reprocessors, which is an added advantage boosting the popularity of dialyzer reprocessing machines and concentrates over conventional systems.

Key Segments Of Dialyzer Reprocessing Machines And Concentrates Industry Survey

Dialyzer Reprocessing Machines and Concentrates Market by Product Type:

Dialyzer Reprocessing Machines
Haemodialysis Concentrates
- Acetic Acid Concentrates
- Citric Acid Concentrates
- Bicarbonates Based Concentrates
- Calcium Free Concentrates
- Potassium Concentrates
Bicarbonate Cartridges
Cold Sterilants and Hot Disinfectants

Dialyzer Reprocessing Machines and Concentrates Market by Form:

Liquid
Powder

Dialyzer Reprocessing Machines and Concentrates Market by End User:

Reprocessing Machines and Concentrates for Hospitals
Reprocessing Machines and Concentrates for Ambulatory Surgical Centres
Reprocessing Machines and Concentrates for Dialysis Centres

Dialyzer Reprocessing Machines and Concentrates Market by Region:

North America Dialyzer Reprocessing Machines and Concentrates Market
Latin America Dialyzer Reprocessing Machines and Concentrates Market
Europe Dialyzer Reprocessing Machines and Concentrates Market
East Asia Dialyzer Reprocessing Machines and Concentrates Market
South Asia & Pacific Dialyzer Reprocessing Machines and Concentrates Market
Middle East & Africa (MEA) Dialyzer Reprocessing Machines and Concentrates Market

Request Your Customized Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-9272

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Medical Physics Market Poised for USD 10 Billion Boom by 2034, at a steady CAGR of 6.4% | FMI Study

According to a recent update from Future Market Insights (FMI), a leading market research firm, the Medical Physics Market is expected to reach a substantial USD 10 billion by 2034. This growth builds on a projected market value of USD 5.3 billion in 2024, reflecting a steady Compound Annual Growth Rate (CAGR) of 6.4%.

Prominently driven by the growth of the medical tourism sector and the increasing expanse of diagnostics, the global revenue of the medical physics market will reportedly thrive at a healthy over 6.2% CAGR during 2022-2028. The growing adoption of nuclear medicine has also been cited as an important factor responsible for a positive growth outlook anticipated for the medical physics market.

Request a Report Sample!
https://www.futuremarketinsights.com/reports/sample/rep-gb-5274

However, the report also highlights that the insufficient availability of skilled workers and relatively poor healthcare infrastructure for medical physicist trainings in developing regional markets will continue to restrict penetration of medical physics in the long run.

The ‘Outsourcing’ Trend Is Creating Firm Base for Merger & Acquisition Strategies

With the consolidation of hospitals, there is an increasing need for larger firms in the medical physics market, with an intent to handle the outsourced services so as to contract with fewer services providers. The medical physics market is characterised by the presence of small independent companies, and there is a negligible number of large-scale operators. According to the report, this presents opportunities for private equity firms to enter the middle-market platform and scale-up their medium-scale operations to large-scale operations through the acquisition of smaller firms.

Other factors driving mergers and acquisitions in the medical physics market include increasing stringent regulations and an increasing number of owners looking to exit the medical physics business. Increasing stringent regulations have resulted in the inspection of a larger number of machines and associated elements. Several healthcare systems are incurring higher risks due to the increasingly stringent regulations. This opens opportunities for medical physics companies to ensure compliance and reduce operation cost by outsourcing. Furthermore, most of the medical physics firms are owned and operated by baby boomers who are about to retire from their medical physics business. For a majority of those medical physics service providers who are retiring, selling their business has been considered to be the most preferred option.

Some of the other trends in the medical physics market include increased outsourcing by healthcare providers, increasing number of independent diagnostic imaging centres, and advancements & adoption of technology across the world.

Segmental Insights: Medical Physics Market

Diagnostic modality, driven by increasing adoption of diagnostic procedures such as PET, SPECT, CT, and MRI, will continue to account for more than 65% share of the total medical physics market value.
Based on services, accreditation assistance is slated to remain dominant, followed by safety surveys. The report anticipates physics testing and regulatory and auditing services to emerge highly potential.
Following hospitals, diagnostic imaging centers are likely to register significant adoption rate in the medical physics market through 2027.

The North American and European medical physics market will reportedly account for a majority of market value, according to FMI’s analysis on medical physics market. The report has attributed this dominance to rapid consolidation of healthcare facilities in these regions.

Request Customization
https://www.futuremarketinsights.com/customization-available/rep-gb-5274

Some of the key players in the medical physics market include Krueger-Gilbert Health Physics, Inc., LANDAUER, Medical Physics Services, Medical Physics Services Consultants, Inc., Alyzen Medical Physics Services, Radiation Safety & Control Services, Inc., Upstate Medical Physics Services, Dade Moeller & Associates, Versant Medical Physics Services & Radiation Safety, Alliance Medical Physics Services LLC, West Physics Consulting, LLC, Associates in Medical Physics Services, Radiation Services, Inc., Jaeger Corporation, and Petrone Associates, LLC.

Medical Physics Market Key Developments:

With a new edition of SmartSignals eConsent in April 2021, Signant Health increased electronic informed consent services and boosted capabilities. To fulfill the study needs of teams, SmartSignals eConsent solutions are available in three categories of functionality: silver, gold, and platinum. This method has improved the company’s existing product offering, resulting in revenue from its sale.

In January 2021, Parexel International Corporation teamed up with Signify Health to provide innovative technologies to improve clinical trial access and inclusion. This collaboration increased patient access to clinical trials by bringing studies to their homes and also identified key social determinants of health (SDoH) to help patients, caregivers, and resources connect.

Medical Physics Market Key Companies Profiled

Medical Physics Services LLC
LANDAEUR
Krueger-Gilbert Health Physics Inc.
Alyzen Medical Physics Services
Radiation Safety & Control Services Inc.
Upstate Medical Physics Services
Dade Moeller & Associates
Versant Medical Physics Services & Radiation Safety
Alliance Medical Physics Services LLC
West Physics Consulting LLC
Associates in Medical Physics Services
Radiation Services Inc.
Jaeger Corporation
Petrone Associates LLC

Purchase the Full Report Now!
https://www.futuremarketinsights.com/checkout/5274

Medical Physics Market Key Segments

By Modality:

Diagnostics
- Radiographic X-Ray Systems
- Fluoroscopic X-Ray Systems
- Dental X-Ray Systems
- Mammography Systems
- Computed Tomography
- Magnetic Resonance Imaging
- Ultrasound
- SPECT
- PET
- Others
Therapeutics
- LINAC
- Brachytherapy
- Others

By Service:

Accreditation Assistance
Performance Testing
Physics Testing
Radiation Dose Monitoring
Radiation Safety Training
Treatment Commissioning Services
Safety Surveys
Regulatory & Auditing Services
Others

By End User:

Hospitals
Ambulatory Surgical Centres
Diagnostic Imaging Centres
Academic & Research Institutes

By Region:

North America
Latin America
Western Europe
Eastern Europe
South Asia and Pacific
East Asia
The Middle East and Africa

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Endoscopic Ultrasound Needles Market is expected to generate USD 223.5 Million, at a CAGR of 4.4% By 2027 | FMI Analysis

The future of minimally invasive diagnostics is looking bright for the Endoscopic Ultrasound Needles Market. A recent study by Future Market Insights (FMI) forecasts a promising trajectory, with the market expected to reach USD 223.5 Million by 2027. This signifies significant growth from a valuation of USD 180.2 Million in 2022.

Endoscopic ultrasound needles are becoming increasingly vital in the medical field, offering minimally invasive procedures and innovative products for fine needle aspiration (FNA) and fine needle biopsy (FNB) for solid lesions. This progress underscores their widespread acceptance among surgeons and healthcare professionals as a safe and effective method, contributing significantly to the growth of the Global Endoscopic Ultrasound needle industry.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-9247

Manufacturers in the Global Endoscopic Ultrasound Needles Industry are focusing on new product launches for more precise diagnosis of tissues collected using needles. Gaining a greater share in the endoscopic ultrasound needles market with diverse portfolio is one of the key strategies of leading players.

As per the report, companies in the Global Endoscopic Ultrasound Needles Industry are also focusing on collaborating for development and distribution of advanced endoscopic ultrasound needle products. Key players in endoscopic ultrasound needles market are focusing on new product development in emerging regions including Latin America and Asia Pacific owing to the increasing prevalence of cancer and other chronic diseases. Endoscopic Ultrasound-Guided Fine Needle Aspiration to Gain Popularity with Rise in Gastrointestinal Diseases

According to the FMI report, Endoscopic Ultrasound-Guided Fine Needle Aspiration (EUS-FNA) is likely to account for largest share in the endoscopic ultrasound needles market. EUS-FNA gaining popularity for the diagnosis of gastrointestinal diseases and peri-gastrointestinal lesions. The wide application of FNA has also accelerated the growth in the endoscopic ultrasound needles market.

With the growing demand for minimally invasive procedures, doctors and surgeons are using EUS combined with FNA to collect sample fluid and tissue from chest and abdomen for diagnosis. It has also emerged as an alternative to exploratory procedure.

Meanwhile, in recent years studies conducted on Endoscopic Ultrasound-Guided Fine Needle Biopsy (EUS-FNB) have shown some promising results. As per the FMI study on endoscopic ultrasound needles market, FNB is emerging as the novel tool in diagnosis by providing information on tissue architecture.

As per the study, ambulatory surgical centres will use endoscopic ultrasound needles on a large scale owing to the rise in number of these centres and increasing number of endoscopic ultrasound surgeries performed in ambulatory surgical centres. Being the minimally invasive and non-surgical procedure that can be performed through colon or upper GI tract, ambulatory surgical centers are gaining traction in the Global Endoscopic Ultrasound Needles Industry.

Moreover, endoscopic ultrasound is generally considered safe when performed at ambulatory surgical centres with expert healthcare team. Various healthcare organisations are building ambulatory surgical centres within the premises in the healthcare facility offering wide range of services with technological advancements to achieve economies of scale.

Get Your Customized Impactful Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-9247

An increasing number of ambulatory surgical centers are offering safe, cost-effective services, especially for gastroenterology, thereby, driving the demand in the Global Endoscopic Ultrasound Needles Industry.

Endoscopic Ultrasound Needles Market Survey

by Product:

Aspiration Needles (EUS-FNA)
Biopsy Needles (EUS-FNB)

by Application:

Bronchial EUS Needles
Enteral EUS Needles

by End User:

Hospitals
Ambulatory Surgical Centers
Specialty Clinics

by Region:

North America Endoscopic Ultrasound Needles Market
Latin America Endoscopic Ultrasound Needles Market
Europe Endoscopic Ultrasound Needles Market
East Asia Endoscopic Ultrasound Needles Market
South Asia & Pacific Endoscopic Ultrasound Needles Market
Middle East & Africa (MEA) Endoscopic Ultrasound Needles Market

Access Exclusive Market Insights – Purchase Now!
https://www.futuremarketinsights.com/checkout/9247

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Allergy Immunotherapy Market is expected to surpass USD 4.07 Billion, growing at a rate of 8.9% CAGR by 2033 | FMI Study

Hope for allergy sufferers is blooming! Future Market Insights (FMI), a leading market research firm, forecasts a significant surge in the global Allergy Immunotherapy Market. In 2023, the market is estimated at a substantial USD 1.74 billion. Looking ahead, a remarkable Compound Annual Growth Rate (CAGR) of 8.9% is projected from 2023 to 2033. By 2033, the market is expected to blossom, reaching an impressive valuation of over USD 4.07 billion.

The burgeoning allergy immunotherapy industry is carving its path to success by adopting principles similar to those utilized in immunotherapy treatments for cancer. While the spotlight often shines on cancer immunotherapy for its innovative approaches, it is essential to acknowledge the growing significance of allergy immunotherapy in addressing allergies, which impact millions of individuals worldwide.

This substantial growth trajectory highlights the market’s potential for substantial advancements in allergy treatment, significantly improving the lives of those suffering from allergies. It also underlines the market’s commitment to harnessing the principles of immunotherapy for the greater good, showcasing innovation that extends beyond the realm of cancer treatment.

Request a Sample Report Now to get Premium Insights:
https://www.futuremarketinsights.com/reports/sample/rep-gb-9043

The predicted revenue growth could be related to the burden of allergy conditions, which are becoming more prevalent globally. The responsibility that complex allergies with increased morbidity place on the healthcare system motivates research and development in this area for the introduction of innovative medicines.

The primary factors propelling the global market are:

The expansion of industrialization and population.
Improvements in healthcare and medicine.
The launch of novel immunotherapeutic medications.

Current regulatory approvals, such as those for oral dissolvable tablets, are further enhanced to gain a larger global allergy immunotherapy industry share.

Compared to other treatments already on the market, sublingual allergy immunotherapy has been clinically shown to be more effective and have fewer adverse effects. Another factor influencing the allergy immunotherapy industry growth is the demographic shift in the population and the macroeconomic environment.

The prevalence of asthma and allergy respiratory illnesses has increased due to rising air pollution levels inside and outside. According to the Asthma and Allergy Association of America (AAFA), rising pollen levels cause more than 25 million allergies.

Europe and North America are the two leading markets for allergy immunotherapy, and they are likely to continue holding a sizable market share during the forecast period. Given the increased awareness, healthcare reimbursement regulations, and growth in the population who suffer from allergies, Europe is estimated to hold a significant portion of the global allergy immunotherapy industry.

“Allergy immunotherapy represents a transformative approach to allergy treatment. This therapeutic method offers long-term relief by desensitizing the immune system to allergens, fundamentally changing how we manage allergies and providing hope for sufferers worldwide.”—by Lead Analyst at Future Market Insights.

KEY TAKEAWAYS:

The market in the United Kingdom is anticipated to rise, exhibiting a CAGR of 9.1% through 2033.
The United States is expected to develop at a 9.1% CAGR during the forecast period.
With a CAGR of 9.3% over the forecast period, Canada is predicted to grow rapidly in the market.
The market in China is expected to increase, registering a CAGR of 8.8% over the forecast period.
Germany is estimated to grow decently, registering a CAGR of 9.7% until 2033.

COMPETITIVE LANDSCAPE:

Top players operating in the allergy immunotherapy market are ALK Abello, Stallergenes Greer, Allergy Therapeutics, Aimmune Therapeutics, Anergis, Arrayit Corporation, Biomay AG, HAL Allergy Group, DBV Technologies, and others.

These key players in the market are developing innovative products, such as sublingual and subcutaneous immunotherapy, to cater to the growing demand for effective allergy treatments. They also invest in research and development to improve existing therapies’ efficacy and safety and expand their market reach through strategic partnerships and collaborations.

RECENT DEVELOPMENTS:

In September 2021, ALK confirmed that by expanding the number of patients by at least 100,000 yearly, it intends to make allergy testing, immunotherapy treatments, and adrenaline products accessible by 2030.
In June 2021, with the complete restoration of SCIT manufacturing in Antony, Stallergenes Greer declared that Alustal®, its subcutaneous allergen immunotherapy (SCIT) remedy, is now accessible in Italy and Spain.

Level Up Your Market Understanding – Buy Now!
https://www.futuremarketinsights.com/checkout/9043

Allergy Immunotherapy Market Segmentation:

Product:

SLIT Tablets

- Odactra
- Grastek
- Ragwitek
- Oralair
- Actair
- Others
Oral
- Palforzia
- Others
Injections
Others

Immunotherapy:

Sublingual Immunotherapy
Subcutaneous Immunotherapy

- Specific Immunotherapy
Others

Indication:

Allergic Rhinitis
Allergic Asthma
Food Allergy
Atopic Dermatitis
Others

Allergen:

Pollens

- Grass Pollens
- Weed Pollens
- Tree Pollens
House Dust Mites
Mold
Animal Dander
Bee Venom
Cockroaches/Insects
Others

Distribution Channel:

Institutional Sales

- Government Hospitals
- Semi-Government Hospitals
- Private Hospitals
Retail Sales
- Retail Pharmacy
- Drug Stores
- Online Pharmacy

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Gastric Electrical Stimulators Market is expected to grow steadily at a 6.1% CAGR and reach USD 433.8 Million by 2033 | FMI

Innovation in gastrointestinal (GI) disorder treatment is sparking a surge in the Gastric Electrical Stimulators Market. This market, focused on implantable devices that regulate stomach contractions, is experiencing steady growth. A recent analysis projects the market to reach a substantial USD 433.8 million by 2033. This signifies a significant rise from its current value of USD 240.6 million in 2023, reflecting a consistent Compound Annual Growth Rate (CAGR) of 6.1%.

Inform Decisions With a Report Sample:
https://www.futuremarketinsights.com/reports/sample/rep-gb-4044

Two main elements are driving this growth:

Technological developments: Patients with chronic stomach disorders like gastroparesis now have a more accurate and maybe more successful therapy option because of the development of high-frequency gastric electrical stimulators. This illness results in delayed stomach emptying, which can induce vomiting, nausea, and malnourishment. For the management of these problems, high-frequency stimulators provide a minimally intrusive option.
Management of chronic diseases: There is an increased need for efficient treatment options due to the growing incidence of chronic diseases such as gastroparesis. For patients who have not responded well to conventional drugs or therapy, gastric electrical stimulators offer a dependable and long-term option.

Gastric electrical stimulators are predicted to become more and more in demand due to the growing senior population’s susceptibility to chronic digestive disorders and the growing emphasis on minimally invasive therapies. This pattern, along with continuing technological developments, bodes well for the stomach electrical stimulator industry.

Gastric Electrical Stimulators Market Key Takeaway:

The global gastric electrical stimulator market is expected to reach US$433.8 million by 2033, growing at a CAGR of 6.1% from its 2023 valuation of US$240.6 million.
Advancements in high-frequency stimulators and their effectiveness in managing chronic conditions like gastroparesis are key growth drivers.

The Dynamic Landscape:

Manufacturers are adopting various marketing strategies such as new product launches, geographical expansion, mergers and acquisitions, partnerships, and collaboration to identify the interests of potential buyers and create a larger customer base. For instance,

IntraPace Inc. was established in 2001 to address an unmet need in weight loss surgery by continuing to develop a gentler solution. The company is focusing on gastric pacing devices that use electrical stimulation to influence gut contractions.

Key Developments in the Gastric Electrical Stimulators Market

Medtronic teamed up with Google, a leader in artificial intelligence, to use AI to improve gastric electrical stimulators. This partnership aims to create a cutting-edge stimulator that can adjust to the needs of each patient, potentially revolutionizing the effectiveness and personalization of treatment.
The INSPIRE Control wireless stomach electrical stimulator, introduced by IntraPace in 2021, represented a significant advance in patient-centered technology. This wireless technology offers a more practical and patient-friendly alternative by not requiring invasive surgery for installation or removal, potentially changing the face of stomach electrical stimulation therapy.

Gastric Electrical Stimulators Market Key Companies Profiled:

Medtronic Plc.
IntraPace Inc.
ReShape Lifesciences Inc.
Changzhou Ruishen Medical Equipment Co. Ltd.
Chen Tao Medical Equipment
Rishena Co. Ltd.
Enterra TM

Secure Your Market Analysis: Purchase Now to Access:
https://www.futuremarketinsights.com/checkout/4044

Key Segments of Gastric Electrical Stimulators Market Survey:

By Type:

High Frequency
Low Frequency

By Application:

Gastroparesis
Obesity

By End User:

Hospitals
Ambulatory Surgical Centers
Other End Users

By Region:

North America
Latin America
Europe
Asia Pacific
The Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Smart Pill Boxes & Bottles Market is expected to grow at a rapid rate of 9.3% CAGR and reach USD 388 Million by 2033 | FMI

Taking medication on schedule just got smarter! The Smart Pill Boxes & Bottles Market is experiencing a surge, fueled by the growing need for improved medication adherence. According to industry estimates, the market reached a value of USD 144.2 million in 2022 and is projected to hit US$160.2 million by 2023. This initial growth is just the beginning, with a robust Compound Annual Growth Rate (CAGR) of 9.3% anticipated from 2023 to 2033. By the end of 2033, the market is expected to reach a staggering USD 388.2 million.

One of the key drivers behind the growth of the smart pill boxes and bottle market is the persistent issue of non-adherence to prescribed medication among adult patients. Studies show that almost 70% of adult patients either discontinue or manipulate their drug therapy, leading to detrimental effects on their health and imposing a significant economic burden on healthcare delivery systems through increased emergency cases and hospitalization.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-1710

Smart pill boxes and bottles are increasingly being perceived as a potential solution to such challenges posed by increased healthcare delivery costs. The significance of medication adherence continues to rise with an increasing prevalence of chronic conditions, propelling demand for the Global Smart Pill Boxes And Bottles Industry.

Dementia and geriatric care remain the key application areas of smart pill boxes and bottles, according to the report. More than 80% of sales are accounted for by aging patients and dementia-afflicted populations. Cancer management is likely to emerge lucrative in terms of applicability in the coming years.

With surging demand for high-quality healthcare delivery, senior care centers, hospitals, long-term care centers, and home care settings are accelerating the adoption of medication dispensers, thereby elevating the revenue growth of the smart pill boxes and bottle market. Some of the leading companies are actively involved in the development of advanced technology medication dispensing devices with zero error risks during medication.

Home care settings maintain the highest consumption share in the smart pill boxes and bottles market which roughly equates to 65% of total sales. Almost a fifth of smart pill boxes and bottles sold are installed at senior care and assisted living centers. FMI’s analysis indicates that long-term care centers are also creating promising

market opportunities for Smart Pill Boxes & Bottles Market manufacturers and distributors.

North America continues to reign supreme owing to early adoption of advanced technology-enabled Global Smart Pill Boxes And Bottles Industry, accounting for more than a third of the global market revenue. The European market for smart pill boxes and bottles also represents a substantial volume share, majorly driven by German patients. South and East Asian regions are briskly developing high-potential markets for manufacturers and distributors of smart pill boxes and bottles, says the report.

The vendor landscape of the smart pill boxes and bottles market remains fairly consolidated and competitive, as Tier 1 manufacturers continue to account for a majority of the share in the market in terms of volume. While the dominance of Koninklijke Philips N.V., PharmRight Corporation & Livi, and AdhereTech prevails in the Global Smart Pill Boxes And Bottles Industry, the report finds that the competition among these players is characterized by product innovation, new launches, and technological advancements.

Access Exclusive Market Insights – Purchase Now!
https://www.futuremarketinsights.com/checkout/1710

Smart Pill Boxes & Bottles Market Key Segment

By product type

Smart Pill Box
Smart Pill Bottles

By indication

dementia
Parkinson’s disease
cancer management
diabetes care
geriatric care
disability
others

By end user

Seniors Care & Assisted Living
Long-Term Care Centers
Home Care Settings

By regions

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa (MEA)

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Anemia Treatment Market is expected to reach USD 14.9 Billion by 2028, Rising at a 6.9% CAGR | FMI Study

Anemia, a condition characterized by a lack of red blood cells, is gaining significant attention, impacting the global treatment market. According to a recent analysis, the Anemia Treatment Market is experiencing a surge, surpassing a value of USD 10.0 billion in 2022. This positive trend is expected to continue, with projections indicating a robust expansion to a staggering USD 14.9 billion by 2028. This translates to a remarkable CAGR (Compound Annual Growth Rate) of 6.9%, reflecting the growing need for effective anemia treatments.

According to a recent report released by Future Market Insights, a significant portion of the demand for Anemia therapy can be attributed to cases arising from one or more chronic medical conditions. This underscores the critical role the industry plays in addressing the healthcare needs of individuals facing anemia associated with various chronic ailments.

The demand for Anemia treatment is chiefly driven by chronic kidney disease (CKD), one of the non-communicable chronic diseases contributing to the demographic shift in emerging regions. Additionally, the increasing popularity of combination therapy is poised to make a substantial impact on the Global Anemia Treatment Industry. The growing utilization of antibiotics, metal chelating agents, erythropoietin-stimulating drugs, and vitamin and iron supplements in combination therapy is recognized as a key driver elevating the prospects of the Anemia treatment Industry in the years to come.

Request a Sample Copy of This Report Now.
https://www.futuremarketinsights.com/reports/sample/rep-gb-8966

Vitamin Supplements Gain Significant Traction for Anemia Treatment

A surge in R&D investments is prominently improving the scope of anemia treatment. Moreover, a rising number of pipeline drugs and the promising potential of biosimilars will contribute to the demand for anemia treatment. However, the high price point associated with biologics continues to mask their superior treatment efficacy over conventional medications.

More than 75% of anemia treatment Industry revenue is accounted by medications, of which, ESAs (erythropoietin stimulating agents) remain bestselling. Blood transfusion is also cited as an important type of anemia treatment, contributing to the market growth. However, the demand for the former is poised for a robust double-digit yearly growth in 2021 and ahead.

The lucrative emergence of ESAs and soaring consumption of other biosimilar medications are likely to introduce new investment opportunities in the Global Anemia Treatment Industry. The extensive availability, accessibility, and economic price point of biosimilar drugs are strongly backed by an increasing number of FDA approvals. This according to FMI will significantly contribute to the improvement of CKD, thereby bolstering the revenue of the anemia treatment Industry. FDA recently issued approval to a biosimilar drug by Pfizer for use in anemia treatment – Retacrit (epoetin alfa-epoxy). Over 55% of dietary supplements consumed as a part of anemia treatment are vitamin supplements. An increasing number of iron-deficient patients will

reportedly result in rapid demand growth for iron supplements in years to come, posing strong competition to those vitamin supplements in the Global Anemia Treatment Industry. Currently, almost 60% of the medications and dietary supplements for anemia treatment are available at institutional pharmacies. The report also points to a gradually expanding share of retail pharmacies shortly.

North American patients raise just under a third of the global demand for anemia treatment, whereas more than a third of the total demand is accounted for collectively by East and South Asia. Europe is also cited as one of the key regional markets for anemia treatment providers.

Product-based Business Models Emerge as a Key Competitive Strategy

The consistent quest for therapeutically effective ESAs, dietary supplements, antibiotics, and other biologics to be used in anemia treatment continues to create attractive avenues in the R&D realm. Leading drug manufacturers are investing efforts in launching novel products and upgrading their existing consumable product portfolios. Amgen’s epoetin alpha has been a breakthrough product since its launch in the CKD treatment landscape and growing adoption continues to benefit the company.

Besides augmenting R&D investments, prominent players in the anemia treatment Industry are also focusing on strategic agreements and partnerships – further paving the way for the development of anemia treatment drugs. The emergence of partnership-based models in the competitive landscape of the anemia treatment market is likely to reshape the R&D structure in the anemia treatment Industry. The report prompts major investment opportunities arising in open collaboration strategies. Several drug manufacturers are also opting for partnerships with regional distribution leaders to form effective product-based distribution channels, particularly targeting developing regional markets.

Access Exclusive Market Insights – Purchase Now!
https://www.futuremarketinsights.com/checkout/8966

Anemia Treatment Market by Category

By Treatment:

Medications
Dietary Supplements

By Disease:

Normocytic anemia
Microcytic anemia
Macrocytic anemia

By Distribution Channel:

Institutional Pharmacies
Retail Pharmacies
Mail Order Pharmacies

Anemia Treatment Market Key Companies Profiled:

Amgen Inc.
Hoffmann-La Roche Ltd.
Novartis AG
Pfizer Inc.
Janssen Pharmaceuticals, Inc.
Teva Pharmaceutical Industries Ltd.
AMAG Pharmaceuticals
Rockwell Medical
Akebia Therapeutics
Vifor Pharma Management Ltd.

Author

Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us: